EFFICACY OF IMMUNOASSAY CHROMATOGRAPHY TEST FOR HEPATITIS-C ANTIBODIES DETECTION

Authors

  • Asia Batool
  • Misbahul Islam Khan
  • Khatoon Akhtar Bano

Abstract

Objective: To asses the efficacy of commercially available tests device method for anti HCVdetection. Methods: Total 2000 blood samples for detection of anti HCV were screened initiallyby immunochromatographic method. Those found positive on initial screening were re-tested byELISA method at the Biochemistry Laboratory of the Pakistan Medical Research Council, FatimaJinnah Medical College, Lahore. Results: Out of a total of 2,000 blood samples, 177 were foundto be initially reactive/positive for anti-HCV with immunochromatographic method. When thesereactive/positive samples were retested for confirmation with ELISA, 47 blood samples werefound to have tested falsely positive for anti-HCV. Overall 2.35% of blood samples were found tobe tested false positive for anti-HCV by immunochromatographic device method. Conclusions:Immunochromatographic device method test is rapid and simple, which can be used in setting withlimited facility when rapid testing is required. However it should not be used as sole criteria fordiagnosis but should serve the purpose of initial screening only. Further research is required toestablish the reliability of such devices for their specificity and sensitivity.Keywords: Immunochromatographic device test, Elisa testing method, anti-HCV, false positive

References

Dal Molin G, Tiribelli C, Campello C. Rational use of

laboratory tests in the diagnosis and management of

Hepatitis C virus infection. Ann Hepatol 2003;2(2):76–83.

WHO. Hepatitis C assays: operational characteristics report.

Blood safety and clinical technology. World Health

Organization Geneva Report 2. 2001.

Wilber JC. Development and use of laboratory tests for

Hepatitis C infections: a review. J Clin Immunoassay

;16:204–7.

Narayan S. Microbes and blood transfusion. Indian J Med

Microbiol 2001;19(3):119–26.

Sayers MH, Beatty PG, Hansen JA. HLA antibodies as a

cause of false-positive reaction. Sreening enzyme

immunoassays for antibodies to human T-lymphotropic

virus type-III. HLA antibodies as a cause of false-positive

reaction. Transfusion 1986;26(1):113–5.

Batool A, Bano KA, Khan MI, Hussain R. Antenatal

screening of women for hepatitis B and C in an out-patient

department of Sir Ganga Ram Hospital Lahore. J Dow Uni

Health Sci 2008;2(1):32–5.

Rahman M, Khan SA, Lodhi Y. Unconfirmed reactive

screening tests and their impact on donors management.

Pak J Med Sci 2008;24(4):517–9.

Wai CT, Tambyah PA. False-positive HIV-1 ELISA in

patients with Hepatitis B. Amer J Med 2002;112(9):737.

Desbois D, Vaghefi P, Savary J, Dussaix E, Roque-Afonso

AM. Sensitivity of a rapid immuno chromatographic test for

hepatitis C antibodies detection. J Clin Virol

;41(2):129–33.

Raghuraman S, Subramaniam T, Abraham P, Sridharan G.

Evaluation of a rapid assay for HCV antibody detection.

Indian J Med Microbiol 1999;17(3):140–1.

Downloads

Published

2009-09-01